bpc-157 vs bpc-159 Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing What Science ACTUALLY Says About

PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165

As such, even though the FDA has not approved its use, we can assume that some adults are already taking it

In some instances, a deficiency in B12 may present symptoms similar to hemolytic anemia, including intramedullary hemolysis and elevated levels of lactate dehydrogenase (LDH), which raises concerns about serious conditions like thrombotic microangiopathy (TMA) [3,4]

There are other treatment options besides UroLift that are definitely viable alternatives